Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BHLHE40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM122C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RIPK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130691 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C1orf228 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR24-2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR3A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BACH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
N4BP2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF2P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NADSYN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on